m+Medelevator.RU
← Поиск публикаций
JACC. Case reports · 2026

Tailoring Antiplatelet Adherence: An EHR-Enabled Model for P2Y12 Inhibitor Therapy Among Veterans.

Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Singh Rudra Pratap, Kelly Breandan, Sachdeva Seerat, Rosenberg Stephanie, Cannon Harmon R, Macdonald Linda

Аннотация

BACKGROUND: The use of P2Y12 inhibitor is highly variable, and administration is frequently confounded by inconsistent documentation that heightens risks for mismanagement, particularly following transitions of care.

PROJECT RATIONALE: Insufficient documentation clearly defining the indication and therapeutic duration for antiplatelet agents carries potential risks for bleeding and/or ischemia. This was observed in patients who were veterans and was felt to represent a modifiable quality gap.

PROJECT SUMMARY: A 2-phase quality improvement initiative at the New Mexico Veterans Affairs Health Care System reviewed documentation among 1,100 veterans prescribed a P2Y12 inhibitor. In a randomly selected sample of 135 patients, 27% lacked documentation clearly defining therapeutic duration, and 8.4% continued P2Y12 inhibitor beyond the intended stop date. A structured electronic health record document and automated reminders were developed using a Plan-Do-Study-Act framework to address these concerns.

TAKE-HOME MESSAGE: Structured electronic health record documentation with automated reminders can improve antiplatelet stewardship and safety.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты